These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15479745)

  • 1. Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids.
    Jones G; Juszczak M; Kingdon E; Harber M; Sweny P; Burns A
    Nephrol Dial Transplant; 2004 Dec; 19(12):3160-4. PubMed ID: 15479745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis.
    Yuan M; Zou J; Zhang X; Liu H; Teng J; Zhong Y; Ding X
    Clin Nephrol; 2010 May; 73(5):354-9. PubMed ID: 20420795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of combination therapy with MMF and steroids for idiopathic membranoproliferative glomerulonephritis].
    Mori Y; Ihara K; Yamaguchi W; Fujii T; Toda T; Nagata M; Matsui N
    Nihon Jinzo Gakkai Shi; 2013; 55(2):177-84. PubMed ID: 23631306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series.
    Avasare RS; Canetta PA; Bomback AS; Marasa M; Caliskan Y; Ozluk Y; Li Y; Gharavi AG; Appel GB
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):406-413. PubMed ID: 29326307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
    Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
    Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.
    Segarra A; Amoedo ML; Martinez Garcia JM; Pons S; Praga M; Garcia EI; Alonso JC; Gascó JM; Pou L; Piera L
    Nephrol Dial Transplant; 2007 May; 22(5):1351-60. PubMed ID: 17311833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
    Sahin GM; Sahin S; Kantarci G; Ergin H
    Nephrology (Carlton); 2007 Jun; 12(3):285-8. PubMed ID: 17498124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil in the treatment of glomerular diseases.
    Grcevska L; Polenakovic M
    Prilozi; 2007 Jul; 28(1):57-68. PubMed ID: 17921918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
    Frutos MA; López V; Alférez MJ; Aranda P
    Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
    Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
    Rabasco C; Cavero T; Román E; Rojas-Rivera J; Olea T; Espinosa M; Cabello V; Fernández-Juarez G; González F; Ávila A; Baltar JM; Díaz M; Alegre R; Elías S; Antón M; Frutos MA; Pobes A; Blasco M; Martín F; Bernis C; Macías M; Barroso S; de Lorenzo A; Ariceta G; López-Mendoza M; Rivas B; López-Revuelta K; Campistol JM; Mendizábal S; de Córdoba SR; Praga M;
    Kidney Int; 2015 Nov; 88(5):1153-60. PubMed ID: 26221755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.
    Hamour IM; Lyster HS; Burke MM; Rose ML; Banner NR
    Transplantation; 2007 Mar; 83(5):570-6. PubMed ID: 17353776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of resistant MPGN type I with mycophenolate mofetil and steroids.
    De S; Al-Nabhani D; Thorner P; Cattran D; Piscione TD; Licht C
    Pediatr Nephrol; 2009 Mar; 24(3):597-600. PubMed ID: 18972137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.
    Tasanarong A; Thitiarchakul S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
    Raimondo ML; Dagher L; Papatheodoridis GV; Rolando N; Patch DW; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2003 Jan; 75(2):186-90. PubMed ID: 12548120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
    Chen X; Chen P; Cai G; Wu J; Cui Y; Zhang Y; Liu S; Tang L
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):796-801. PubMed ID: 12126522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.